{"id":411491,"date":"2025-11-20T13:30:00","date_gmt":"2025-11-20T12:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=411491"},"modified":"2025-11-20T14:29:44","modified_gmt":"2025-11-20T13:29:44","slug":"pan-jak-i-topico-vs-retinoide-sistemico-studio-testa-a-testa","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/it\/pan-jak-i-topico-vs-retinoide-sistemico-studio-testa-a-testa\/","title":{"rendered":"Pan-JAK-i topico vs. retinoide sistemico: studio testa a testa"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>L&#8217;alitretinoina \u00e8 attualmente l&#8217;unico trattamento sistemico autorizzato per l&#8217;eczema cronico grave delle mani, quando i pazienti non rispondono adeguatamente ai corticosteroidi topici. L&#8217;inibitore topico della pan-janus chinasi (JAK) delgocitinib \u00e8 ora disponibile anche come ulteriore opzione di escalation per questi casi. Nello studio DELTA-FORCE, le due opzioni terapeutiche sono state confrontate direttamente, e delgocitinib si \u00e8 dimostrato superiore.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fpan-jak-i-topico-vs-retinoide-sistemico-studio-testa-a-testa%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>L&#8217;alitretinoina \u00e8 attualmente l&#8217;unico trattamento sistemico autorizzato per l&#8217;eczema cronico grave delle mani, quando i pazienti non rispondono adeguatamente ai corticosteroidi topici. L&#8217;inibitore topico della pan-janus chinasi (JAK) delgocitinib \u00e8&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fpan-jak-i-topico-vs-retinoide-sistemico-studio-testa-a-testa%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":411492,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Eczema cronico delle mani  ","footnotes":""},"category":[11550,11343,11351,11519,11415,11515],"tags":[82428,80598,86005,33109,86004,86003,14355],"powerkit_post_featured":[],"class_list":["post-411491","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-it","category-allergologia-e-immunologia-clinica","category-dermatologia-e-venereologia","category-formazione-continua","category-infettivologia","category-studi","tag-anzupgo-it","tag-delgocitinib-it","tag-delta-force","tag-eczema-cronico-delle-mani","tag-retinoide-sistemico","tag-studio-testa-a-testa","tag-topico","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-13 11:53:50","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"it_IT","wpml_translations":{"pt_PT":{"locale":"pt_PT","id":411488,"slug":"pan-jak-i-topico-vs-retinoide-sistemico-estudo-comparativo","post_title":"Pan-JAK-i t\u00f3pico vs. retinoide sist\u00e9mico: estudo comparativo","href":"https:\/\/medizinonline.com\/pt-pt\/pan-jak-i-topico-vs-retinoide-sistemico-estudo-comparativo\/"},"es_ES":{"locale":"es_ES","id":411485,"slug":"pan-jak-i-topico-frente-a-retinoide-sistemico-estudio-comparativo","post_title":"Pan-JAK-i t\u00f3pico frente a retinoide sist\u00e9mico: estudio comparativo","href":"https:\/\/medizinonline.com\/es\/pan-jak-i-topico-frente-a-retinoide-sistemico-estudio-comparativo\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/411491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/comments?post=411491"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/411491\/revisions"}],"predecessor-version":[{"id":411493,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/411491\/revisions\/411493"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media\/411492"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media?parent=411491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/category?post=411491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/tags?post=411491"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/powerkit_post_featured?post=411491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}